{"id":"n_alip2k3pv6qb6ffgo52q","seq":12697273,"kind":"press_release","title":"FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis","url":"https://www.globenewswire.com/news-release/2026/11/19/3406254/0/en/fda-approves-livsayis-cemdisiran-for-adults-living-with-generalized-myasthenia-gravis.html","summary":"This new treatment is the first and only FDA approved siRNA therapy for gMG, expanding the therapeutic landscape for people living with myasthenia gravis. This new treatment is the first and only FDA approved siRNA therapy for gMG, expanding the therapeutic landscape for people living with myasthenia gravis.","published":"2026-11-19T00:34:00Z","seen":"2026-11-19T00:40:51Z","lang":"en","country":"US","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com"},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://ml.globenewswire.com/Resource/Download/7d124013-12bc-4fdd-8fa5-dc2a9658fe43","story":"st_kleyywnscs3hsb3rzgza","category":"health","category_p":0.47,"sentiment":"positive","tone":0.46,"political":0.11}